NCT04075188View on ClinicalTrials.gov

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

July 13, 2019

Conditions
Choroidal NeovascularizationChoroid Disease
Interventions
DRUG

Aflibercept Injection

Patients will be treated with combined therapy to determine the synergy of this treatment, causing anti- Vascular Endothelial Growth Factor (anti-VEGF) to block neovascular exudation and photodynamic therapy to close aneurismal vessel and reduce choroidal vascular congestion.

Trial Locations (1)

90127

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo

All Listed Sponsors
lead

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

OTHER

NCT04075188 - Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid | Biotech Hunter | Biotech Hunter